Micaela S. Ossowski

B, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

A PQQ-dependent oxidoreductase in Trypanosoma cruzi reveals a novel redox activity in a eukaryotic pathogen.

A PQQ-dependent oxidoreductase in Trypanosoma cruzi reveals a novel redox activity in a eukaryotic pathogen.

Journal: Frontiers in cellular and infection microbiology
Published: February 27, 2026

Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries.

Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries.

Journal: PLoS neglected tropical diseases
Published: January 05, 2026

The diagnostic value of two antigenic domains derived from the Trypanosoma cruzi Tc323 protein in chronic Chagas disease: a study in Brazil.

The diagnostic value of two antigenic domains derived from the Trypanosoma cruzi Tc323 protein in chronic Chagas disease: a study in Brazil.

Journal: Frontiers in microbiology
Published: April 03, 2025

Performance Assessment of ELISA Using the Trypanosoma cruzi-Specific Antigen Tc323 for the Diagnosis of Chronic Chagas Disease.

Performance Assessment of ELISA Using the Trypanosoma cruzi-Specific Antigen Tc323 for the Diagnosis of Chronic Chagas Disease.

Journal: ACS infectious diseases
Published: November 16, 2024

Characterization of Novel Trypanosoma cruzi-Specific Antigen with Potential Use in the Diagnosis of Chagas Disease.

Characterization of Novel Trypanosoma cruzi-Specific Antigen with Potential Use in the Diagnosis of Chagas Disease.

Journal: International journal of molecular sciences
Published: November 07, 2023

Expression of Inhibitory Receptors TIGIT, TIM-3, and LAG-3 on CD4+ T Cells from Patients with Different Clinical Forms of Chronic Chagas Disease.

Expression of Inhibitory Receptors TIGIT, TIM-3, and LAG-3 on CD4+ T Cells from Patients with Different Clinical Forms of Chronic Chagas Disease.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 17, 2022

Trypanosoma cruzi Induces Regulatory B Cell Alterations in Patients With Chronic Chagas Disease.

Trypanosoma cruzi Induces Regulatory B Cell Alterations in Patients With Chronic Chagas Disease.

Journal: Frontiers in cellular and infection microbiology
Published: June 10, 2021

Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Journal: EBioMedicine
Published: September 08, 2020

Ex vivo characterization of Breg cells in patients with chronic Chagas disease.

Ex vivo characterization of Breg cells in patients with chronic Chagas disease.

Journal: Scientific reports
Published: February 06, 2020

In Silico Guided Discovery of Novel Class I and II Trypanosoma cruzi Epitopes Recognized by T Cells from Chagas' Disease Patients.

In Silico Guided Discovery of Novel Class I and II Trypanosoma cruzi Epitopes Recognized by T Cells from Chagas' Disease Patients.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 23, 2019

Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.

Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.

Journal: Immunology
Published: April 20, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026